EN
0
Home > Products > Pharmaceuticals & Life Science > API & Advanced Intermediates > Lithium Citrate Tribasic Tetrahydrate
Lithium Citrate Tribasic Tetrahydrate structure, CAS 919-16-4

Lithium Citrate Tribasic Tetrahydrate

CAS Number919-16-4

Synonymslithium citrate

Molecular FormulaHOC(COOLi)(CH2COOLi)2 · 4H2O

Molecular Weight281.98

Purity≥99.5 (NT)%

Density1.12 g/mL at 20 °C

Boiling Point309.6ºC at 760mmHg

Melting Point

Flash Point

Appearancesolid

EINECS213-045-8

MSDSChineseEnglish

Symbol

Signal Word

Cat. No.: 2A-9092352 Purity: ≥99.5 (NT)%
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Inquiry

Quality Control of [ 919-16-4 ] Purity: ≥99.5 (NT)% SDS Specification MoL

COA NMR CNMR HPLC LC-MS
Chemical & Physical Properties
CAS Number919-16-4
Catalog No.2A-9092352
Chinese Name柠檬酸锂
Synonymslithium citrate
Molecular FormulaHOC(COOLi)(CH2COOLi)2 · 4H2O
Molecular Weight281.98
Purity≥99.5 (NT)
Density1.12 g/mL at 20 °C
Boiling Point309.6ºC at 760mmHg
Appearancesolid
Water SolubilityH2O: 1 M at 20 °C, clear, colorless
Storage Conditionroom temperature
ApplicationLithium citrate reduces excess N-acetyl aspartate in the brains of patients with Canavan disease [1].
EINECS213-045-8
PubChem ID329759732
MDL NumberMFCD00150030
SMILES[Li+].[Li+].[Li+].O.O.O.O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
InChI1S/C6H8O7.3Li.4H2O/c7-3(8)1-6(13,5(11)12)2-4(9)10;;;;;;;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;;4*1H2/q;3*+1;;;;/p-3
InChI KeyHXGWMCJZLNWEBC-UHFFFAOYSA-K
NACRES CodeNA.25
UNSPSC12161700
MSDSmsds/92352_1_919_16_4.pdf
BioactivityLithium citrate reduces excessive intra-cerebral N-acetyl aspartate in Canavan disease[1]. Related Catalog Signaling Pathways >> Others >> Others Research Areas >> Neurological Disease References [1]. Mitra Assadi, et al. Lithium citrate reduces excessive intra-cerebral N-acetyl aspartate in Canavan disease. Eur J Paediatr Neurol. 2010 Jul;14(4):354-9. Chemical & Physical Properties Density 1.12 g/mL at 20 °C Boiling Point 309.6ºC at 760mmHg Molecular Formula C6H5Li3O7 Molecular Weight 209.92300 Flash Point 155.2ºC Exact Mass 210.05200 PSA 140.62000 InChIKey WJSIUCDMWSDDCE-UHFFFAOYSA-K SMILES O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[Li+].[Li+].[Li+] Stability Stable. Incompatible with strong oxidizing agents. Water Solubility H2O: 1 M at 20 °C, clear, colorless
Use ofLithium citrate reduces excessive intra-cerebral N-acetyl aspartate in Canavan disease[1]. Properties Name Lithium citrate tribasic tetrahydrate Synonym More Synonyms lithium citrate Biological Activity Description Lithium citrate reduces excessive intra-cerebral N-acetyl aspartate in Canavan disease[1]. Related Catalog Signaling Pathways >> Others >> Others Research Areas >> Neurological Disease References [1]. Mitra Assadi, et al. Lithium citrate reduces excessive intra-cerebral N-acetyl aspartate in Canavan disease. Eur J Paediatr Neurol. 2010 Jul;14(4):354-9. Chemical & Physical Properties Exact Mass 210.05200 PSA 140.62000 InChIKey WJSIUCDMWSDDCE-UHFFFAOYSA-K SMILES O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[Li+].[Li+].[Li+] Stability Stable. Incompatible with strong oxidizing agents.
Transport InfoProduct name: Lithium citrate
Related Products in API & Advanced Intermediates
VERAPAMIL HYDROCHLORIDE23313-68-02A-9092196
GEMIFLOXACIN MESYLATE214346-13-12A-9092206
4-HYDROXYMIDAZOLAM59468-85-82A-9092230
Diclofenac diethyl ammonium2A-1739502A-9092275
Diclofenac Diethylammonium 2A-2739512A-9092276
Demethyl Memantine Hydrochloride33103-93-42A-9092379
ERYTHROMYCIN B (150 MG)527-75-32A-9092427
diltiazem hydrochloride103532-26-92A-9092438
Tenofovir Phosphate Diammonia Salt, >90%2A-1741532A-9092480
3',5'-Dihydrodiol SiMvastatin (Mixture of DiastereoMers)159143-77-82A-9092514
Browse all API & Advanced Intermediates products »
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA